Studies on human melanoma biopsies found an IFNγ signature to be associated with a high response to checkpoint inhibitor therapy in patients, and in vitro exposure of 58 distinct human cell lines to IFNγ induced a similar signature [107]. The gene discussed is IFNG; the disease is melanoma.